Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
For practical guidance on managing appetite changes, this article on appetite suppression timelines is worth reading
The information provided on this page is intended solely for scientific and educational reference purposes
In our own UAE clinical practice we have observed that a subset of GLP-1 patients who have plateaued show renewed progress after the addition of AOD-9604, in carefully selected cases where the foundation has been addressed first
Accelerates new blood vessel formation and gut-brain axis healing through growth factor modulation
It works by mimicking ghrelin , the hunger hormone, and binding to the growth hormone secretagogue receptor (GHS-R1a) without increasing cortisol or prolactin levels like older peptides such as GHRP-6 or GHRP-2
Based on available research and anecdotal reports: Week 1 to 2: Initial reduction in inflammation and pain may be noticed Some users report improved mobility at injury sites Gastrointestinal benefits may become apparent for those using oral forms Week 2 to 4: More noticeable improvements in tissue healing Continued reduction in inflammation Enhanced range of motion and functional recovery Week 4 to 8: Significant structural improvements in healing tissues Continued functional gains Many users report substantial recovery milestones The peptide has a relatively short half-life of less than 30 minutes, following linear pharmacokinetics after administration
